Shan Chun Wang
Fortune : 7 M $ au 31/07/2026
Fortune : 7 M $ au 31/07/2026
Shan Chun Wang formerly worked at Sino Biopharmaceutical Ltd., as Executive Director from 2015 to 2022, Sinomab Bioscience Ltd., as Executive Director from 2024 to 2025, and Chia Tai-Tianqing Pharmaceutical Holdings Co., Ltd., as President from 2015 to 2022.
Mr. Wang received his graduate degree in 2002 from Tianjin University and undergraduate degree in 1990 from Nanjing University of Chemistry.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/05/2025 | 43 127 200 ( 3,11% ) | 7 M $ | 31/07/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| SINOMAB BIOSCIENCE LIMITED | Directeur/Membre du Conseil | 09/06/2025 |
| SINO BIOPHARMACEUTICAL LIMITED | Directeur/Membre du Conseil | 02/11/2022 |
Chia Tai-Tianqing Pharmaceutical Holdings Co., Ltd. | President | 01/01/2022 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Sino Biopharmaceutical Ltd.
Sino Biopharmaceutical Ltd. Pharmaceuticals: MajorHealth Technology Operates as an investment holding company, which engages in the manufacturing and selling of pharmaceutical products | Health Technology |
Tianjin University
Tianjin University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanjing University of Chemistry
Nanjing University of Chemistry Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sinomab Bioscience Ltd.
Sinomab Bioscience Ltd. BiotechnologyHealth Technology Manufactures and distributes antibodies | Health Technology |
Chia Tai-Tianqing Pharmaceutical Holdings Co., Ltd. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national